Veracyte Inc. (VCYT) Financial Statements (2025 and earlier)

Company Profile

Business Address 6000 SHORELINE COURT, SUITE 300
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 8071 - Medical Laboratories (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2025
MRQ
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:289,400216,500178,900173,197349,364159,317
Cash and cash equivalent239,087216,454154,247173,197349,364159,317
Other undisclosed cash, cash equivalents, and short-term investments 50,3134624,653   
Receivables46,52540,37844,02141,46118,46119,329
Inventory, net of allowances, customer advances and progress billings21,75016,12814,29411,2254,6576,806
Inventory21,75016,12814,29411,2254,6576,806
Other undisclosed current assets14,59212,61511,42117,2193,1972,235
Total current assets:372,267285,621248,636243,102375,679187,687
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization  100    
Operating lease, right-of-use asset48,18910,27713,16016,0437,8438,808
Property, plant and equipment     8,9908,933
Intangible assets, net (including goodwill)848,101791,577870,757910,63562,64967,744
Goodwill745,800702,984695,891707,9042,7252,725
Intangible assets, net (excluding goodwill)102,30188,593174,866202,73159,92465,019
Restricted cash and investments1,544876749749603603
Other noncurrent assets6,9815,9715,4182,1981,3991,437
Other undisclosed noncurrent assets22,95320,48417,70215,098  
Total noncurrent assets:927,768829,285907,786944,72381,48487,525
TOTAL ASSETS:1,300,0351,114,9061,156,4221,187,825457,163275,212
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities52,46051,37049,68551,83514,82116,062
Accounts payable8,63412,94311,91112,3603,1162,328
Accrued liabilities43,82638,42737,77439,47511,70513,734
Deferred revenue1,6732,0082,6134,646371 
Debt    1,127 1,407
Business combination, contingent consideration, liability16,9812,6576,0602,682  
Other liabilities 19101186231  
Other undisclosed current liabilities7,5005,1054,0703,6301,589 
Total current liabilities:78,63361,24162,61464,15116,78117,469
Noncurrent Liabilities
Long-term debt and lease obligation    14,09610,72712,200
Long-term debt, excluding current maturities     810694
Liabilities, other than long-term debt44,8759,04516,1107,342829 
Deferred revenue    343829 
Deferred income tax liabilities1,2277344,5315,592  
Other liabilities4117869311,407  
Operating lease, liability43,2377,52510,64814,0969,91711,506
Other undisclosed noncurrent liabilities5615182,4985,7227,5946,088
Total noncurrent liabilities:45,4369,56318,60827,16019,15018,288
Total liabilities:124,06970,80481,22291,31135,93135,757
Equity
Equity, attributable to parent1,175,9661,044,1021,075,2001,096,514421,232239,455
Common stock787372715850
Additional paid in capital1,655,9611,536,1681,500,1911,468,683702,768486,090
Accumulated other comprehensive loss(36,090)(24,018)(31,346)(15,083)  
Accumulated deficit(443,983)(468,121)(393,717)(357,157)(281,594)(246,685)
Total equity:1,175,9661,044,1021,075,2001,096,514421,232239,455
TOTAL LIABILITIES AND EQUITY:1,300,0351,114,9061,156,4221,187,825457,163275,212

Income Statement (P&L) ($ in thousands)

6/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues445,764361,051296,536219,514117,483120,368
Cost of revenue(11,552)(112,632)(98,076)(74,400)(41,455)(36,077)
Cost of product and service sold(11,552)   (1,088)(446)
Other undisclosed gross profit(136,067)     
Gross profit:298,145248,419198,460145,11476,02884,291
Operating expenses(278,706)(334,214)(239,541)(227,017)(111,417)(97,571)
Other undisclosed operating loss(3,297)    (1,847)
Operating income (loss):16,142(85,795)(41,081)(81,903)(35,389)(15,127)
Nonoperating income9,6029,1834,6542547433,205
Other nonoperating income9,6029,1834,6542547093,205
Interest and debt expense     (229)(677)
Income (loss) from continuing operations before equity method investments, income taxes:25,744(76,612)(36,427)(81,649)(34,875)(12,599)
Other undisclosed income from continuing operations before income taxes     7599
Income (loss) from continuing operations before income taxes:25,744(76,612)(36,427)(81,649)(34,800)(12,500)
Income tax expense (benefit)(1,606)2,208(133)6,086  
Income (loss) from continuing operations:24,138(74,404)(36,560)(75,563)(34,800)(12,500)
Loss before gain (loss) on sale of properties:(75,563)(34,800)(12,500)
Net income (loss):24,138(74,404)(36,560)(75,563)(34,800)(12,500)
Other undisclosed net loss attributable to parent     (109) 
Net income (loss) attributable to parent:24,138(74,404)(36,560)(75,563)(34,909)(12,500)
Other undisclosed net loss available to common stockholders, basic      (99)
Net income (loss) available to common stockholders, diluted:24,138(74,404)(36,560)(75,563)(34,909)(12,599)

Comprehensive Income ($ in thousands)

6/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net income (loss):24,138(74,404)(36,560)(75,563)(34,800)(12,500)
Comprehensive income (loss):24,138(74,404)(36,560)(75,563)(34,800)(12,500)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(12,072)7,328(16,263)(15,083) (99)
Comprehensive income (loss), net of tax, attributable to parent:12,066(67,076)(52,823)(90,646)(34,800)(12,599)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: